AAV gene therapy targets autoimmune uveitis
Study examines immunomodulatory therapy as a potential long-term treatment option.
Study examines immunomodulatory therapy as a potential long-term treatment option.
Researchers examined disparities in service coverage of pediatric ophthalmologists and pediatric optometrists in relation to patient demographics to cast a light on at-risk populations and…
The data will be presented in oral session at the 2024 American Society of Gene & Cell Therapy meeting May 7-11 in Baltimore, Maryland.
The tool shows disease progression and vision loss simulations for multiple diseases such as AMD, XLRP, and achromatopsia
Rick Lewis, chief medical officer of ViaLase, describes the company’s nonincisional glaucoma treatment, showing promising safety and efficacy in studies and possibly paving the way…
Researchers found the model demonstrated “near-perfect” detection capabilities.
Donahue will serve as president until June 30, 2025, when he will host the AAPOS 2025 annual meeting in Salt Lake City, Utah. He previously…
Researchers examined disparities in service coverage of pediatric ophthalmologists and pediatric optometrists in relation to patient demographics to cast a light on at-risk populations and…
The company announced results from a Phase IV study of tropicamide and phenylephrine hydrochloride ophthalmic spray 1%/2.5% (Mydcombi) designed to characterize the efficacy and duration…
Neda Nikpoor, MD, urges audience members to become more empowered in making small but meaningful, evidence-based changes in combating unconscious gender bias.
The tool shows disease progression and vision loss simulations for multiple diseases such as AMD, XLRP, and achromatopsia